This brand name is authorized in France, Tunisia.
The drug NIFLURIL contains one active pharmaceutical ingredient (API):
1
|
UNII
4U5MP5IUD8 - NIFLUMIC ACID
|
|
Niflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M01AX02 | Niflumic acid | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AX Other antiinflammatory and antirheumatic agents, non-steroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FR | Base de données publique des médicaments | 60988883, 66085510, 68820460 |
| TN | Direction de la Pharmacie et du Médicament | 9133041, 9133042, 9133043H, 9133044H |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.